drugset / Trial / NCT01192191
A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 in Japanese Subjects With COPD
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary purpose of the study is to evaluate the safety and tolerability of fluticasone furoate/GW642444 inhalation powder when administered once-daily for 52 weeks in Japanese patients with COPD.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone Furoate | Other / unclassified | 100 ug | Inhaled |
| Subject | Fluticasone Furoate | Other / unclassified | 200 ug | Inhaled |
| Subject | Vilanterol | Other / unclassified | 25 ug | Inhaled |